Loading...

Boston Partners Long/Short Research Fd Inv Cl

BPRRX•NASDAQ
Financial Services
Asset Management - Leveraged
$14.07
$0.010(0.07%)

Boston Partners Long/Short Research Fd Inv Cl (BPRRX) Stock Overview

Explore Boston Partners Long/Short Research Fd Inv Cl’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 69.4/100

Key Financials

Market Cap530.2M
P/E Ratio0.00
EPS (TTM)N/A
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 Week$13.64
1 Month$13.72
3 Months$13.68
1 Year Target$13.10

BPRRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Boston Partners Long/Short Research Fd Inv Cl (BPRRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 64.50, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $13.10.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 530.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
4.33%
5-Day Change
3.91%
1-Month Change
-0.39%
3-Month Change
-0.93%
6-Month Change
-12.53%
Year-to-Date (YTD) Change
-0.85%
1-Year Change
-6.31%
3-Year Change
-19.79%
5-Year Change
-2.07%
All-Time (Max) Change
22.79%

Contact Information

888-261-4073
RBB Fund Inc (Robeco), MD

Company Facts

IPO DateNov 29, 2010
CountryUS
Actively Trading

Frequently Asked Questions

;